Butterfly Network Receives FDA Clearance For Fully Automated Gestational Age Tool

Butterfly Network, Inc. (NYSE: BFLY) has received FDA clearance for its fully automated Gestational Age Tool, which is integrated into its handheld ultrasound solution. This tool is notable as it is the first FDA-cleared blind-sweep ultrasound AI tool designed for estimating gestational age.